Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LNSR | US
0.02
0.16%
Healthcare
Medical Devices
30/06/2024
05/03/2026
12.21
12.05
12.23
11.94
LENSAR Inc. a commercial-stage medical device company focuses on designing developing and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes efficiency and reproducibility by providing imaging procedure planning design and precision. The company also offers Adaptive Cataract Treatment System a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR Inc. was incorporated in 2004 and is headquartered in Orlando Florida.
View LessStrength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
21.1%1 month
29.4%3 months
30.7%6 months
34.1%-
-
2.84
0.05
0.03
-1.04
1.22
-
-7.14M
141.74M
141.74M
-
-12.27
-
5.20
-29.95
2.48
0.70
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.12
Range1M
1.56
Range3M
2.52
Rel. volume
1.18
Price X volume
641.92K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| CVRx Inc. | CVRX | Medical Devices | 8.37 | 155.64M | -1.41% | n/a | 55.37% |
| Inogen Inc | INGN | Medical Devices | 6.55 | 155.36M | 3.80% | n/a | 11.43% |
| Nano-X Imaging Ltd. | NNOX | Medical Devices | 2.59 | 151.51M | -2.26% | n/a | 4.41% |
| Nyxoah SA | NYXH | Medical Instruments & Supplies | 3.72 | 140.09M | -5.58% | n/a | 10.60% |
| TriSalus Life Sciences Inc. | TLSI | Medical Devices | 4.77 | 139.82M | -4.60% | 0.08 | -94.26% |
| Fonar Corporation | FONR | Medical Devices | 18.57 | 119.89M | 0.22% | 10.25 | 25.11% |
| Apyx Medical Corporation | APYX | Medical Instruments & Supplies | 3.26 | 112.94M | -1.21% | n/a | 262.43% |
| PAVmed Inc | PAVM | Medical Devices | 10.41 | 103.58M | -0.86% | n/a | -67.66% |
| MaxCyte Inc. Common Stock | MXCT | Medical Devices | 0.8356 | 88.28M | 8.89% | n/a | 8.37% |
| Xtant Medical Holdings Inc | XTNT | Medical Devices | 0.63 | 87.39M | 0.00% | n/a | 77.74% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 41 | 117.74M | -0.58% | 5.16 | 19.82% |
| STHO | STHO | Real Estate Services | 8.61 | 114.68M | -0.92% | n/a | 59.21% |
| Comstock Holding Companies Inc | CHCI | Real Estate Services | 11.55 | 113.90M | 0.17% | 14.10 | 17.12% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.31 | 102.79M | 0.48% | 9.09 | 39.79% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.43 | 71.57M | -1.12% | 14.48 | 7.10% |
| The InterGroup Corporation | INTG | Real Estate Services | 32.63 | 71.10M | 1.12% | n/a | -238.17% |
| ILAG | ILAG | Building Products & Equipment | 2.32 | 41.90M | 0.87% | n/a | 5.48% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.29 | 33.46M | -2.04% | 0.03 | 16.03% |
| Ohmyhome Limited Ordinary Shares | OMH | Real Estate Services | 1.19 | 27.65M | -2.46% | n/a | 11.23% |
| OPAD | OPAD | Real Estate Services | 0.7499 | 20.51M | -1.58% | n/a | 406.11% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.04 | - | Cheaper |
| Ent. to Revenue | 1.22 | - | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 2.84 | 6.21 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 30.69 | - | Lower Risk |
| Debt to Equity | 0.05 | -145.53 | Expensive |
| Debt to Assets | 0.03 | 0.35 | Cheaper |
| Market Cap | 141.74M | - | Emerging |